Kaufman HL - Search Results

1

Insertion of interleukin-2 (IL-2) and interleukin-12 (IL-12) genes into vaccinia virus results in effective anti-tumor responses without toxicity.

Kaufman HL, Flanagan K, Lee CS, Perretta DJ, Horig H. Kaufman HL, et al. Vaccine. 2002 Mar 15;20(13-14):1862-9. doi: 10.1016/s0264-410x(02)00032-4. Vaccine. 2002. PMID: 11906776

2

Combination interleukin-2 and interleukin-12 induces severe gastrointestinal toxicity and epithelial cell apoptosis in mice.

Kaufman HL, Swartout BG, Hörig H, Lubensky I. Kaufman HL, et al. Cytokine. 2002 Jan 7;17(1):43-52. doi: 10.1006/cyto.2001.0986. Cytokine. 2002. PMID: 11886170

3

Prostate-specific antigen vaccines for prostate cancer.

Hörig H, Lee CS, Kaufman HL. Hörig H, et al. Among authors: kaufman hl. Expert Opin Biol Ther. 2002 Apr;2(4):395-408. doi: 10.1517/14712598.2.4.395. Expert Opin Biol Ther. 2002. PMID: 11955277 Review.

4

Local delivery of recombinant vaccinia virus expressing secondary lymphoid chemokine (SLC) results in a CD4 T-cell dependent antitumor response.

Flanagan K, Glover RT, Hörig H, Yang W, Kaufman HL. Flanagan K, et al. Among authors: kaufman hl. Vaccine. 2004 Jul 29;22(21-22):2894-903. doi: 10.1016/j.vaccine.2003.12.021. Vaccine. 2004. PMID: 15246626

5

Immunotherapy for pancreatic cancer: current concepts.

Kaufman HL, Di Vito J Jr, Hörig H. Kaufman HL, et al. Hematol Oncol Clin North Am. 2002 Feb;16(1):159-97, viii. doi: 10.1016/s0889-8588(01)00002-8. Hematol Oncol Clin North Am. 2002. PMID: 12063825 Review.

6

Poxviruses as vectors for cancer immunotherapy.

Kwak H, Hörig H, Kaufman HL. Kwak H, et al. Among authors: kaufman hl. Curr Opin Drug Discov Devel. 2003 Mar;6(2):161-8. Curr Opin Drug Discov Devel. 2003. PMID: 12669450 Review.

7

Local delivery of poxvirus vaccines for melanoma.

Hörig H, Kaufman HL. Hörig H, et al. Among authors: kaufman hl. Semin Cancer Biol. 2003 Dec;13(6):417-22. doi: 10.1016/j.semcancer.2003.09.005. Semin Cancer Biol. 2003. PMID: 15001160 Review.

8

Targeting the local tumor microenvironment with vaccinia virus expressing B7.1 for the treatment of melanoma.

Kaufman HL, Deraffele G, Mitcham J, Moroziewicz D, Cohen SM, Hurst-Wicker KS, Cheung K, Lee DS, Divito J, Voulo M, Donovan J, Dolan K, Manson K, Panicali D, Wang E, Hörig H, Marincola FM. Kaufman HL, et al. J Clin Invest. 2005 Jul;115(7):1903-12. doi: 10.1172/JCI24624. Epub 2005 Jun 2. J Clin Invest. 2005. PMID: 15937544 Free PMC article. Clinical Trial.

9

Current issues in cancer vaccine development.

Hörig H, Kaufman HL. Hörig H, et al. Among authors: kaufman hl. Clin Immunol. 1999 Sep;92(3):211-23. doi: 10.1006/clim.1999.4751. Clin Immunol. 1999. PMID: 10479526 Review. No abstract available.

10

Innovative treatments for pancreatic cancer.

Lieberman SM, Hörig H, Kaufman HL. Lieberman SM, et al. Among authors: kaufman hl. Surg Clin North Am. 2001 Jun;81(3):715-39. doi: 10.1016/s0039-6109(05)70157-2. Surg Clin North Am. 2001. PMID: 11459285 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

242 results

Search Page

Filters